Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients who have Alagille Syndrome (AGS) also frequently have blockages (or "stenoses") of their pulmonary arteries. Little is known about the degree or variability of these stenoses, or the effect of this disease on the right ventricle (the chamber of the heart which pumps blood to the lungs). This study will first quantify and describe pulmonary artery stenosis in patients with Alagille Syndrome. The study will also assess the effect of these stenoses on the right ventricle. The investigators hope to learn the degree and characteristics of pulmonary artery stenosis in Alagille Syndrome. The investigators also hope to learn the effect of this pulmonary artery stenosis on the right ventricle in patients with Alagille Syndrome. This information is critical in the management of patients with Alagille syndrome, as there is currently no data to guide clinicians on the management of pulmonary artery stenosis. Furthermore, the information from this study may help physicians manage pulmonary artery stenosis in other patients as well.
| Condition |
|---|
|
Alagille Syndrome |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Retrospective |
| Estimated Enrollment: | 25 |
| Study Start Date: | April 2007 |
| Groups/Cohorts |
|---|
|
Study
Patients with alagille syndrome
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with Alagille Syndrome. The age range will be from birth through adulthood. There will be no gender or ethnic limitations to study.
Inclusion Criteria:
- Diagnosis of Alagille Syndrome
Exclusion Criteria:
- None
Contacts and Locations| Contact: Jeffrey Feinstein, MD, MPH | 650 723 7913 | jaf@stanford.edu |
| United States, California | |
| Lucile Packard Children's Hospital at Stanford | Recruiting |
| Palo Alto, California, United States, 94304 | |
| Principal Investigator: Jeffrey Feinstein, MD, MPH | |
More Information
No publications provided
| Responsible Party: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT01515631 History of Changes |
| Other Study ID Numbers: | AG9031 |
| Study First Received: | January 18, 2012 |
| Last Updated: | January 23, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Alagille Syndrome Cholestasis, Intrahepatic Cholestasis Bile Duct Diseases Biliary Tract Diseases Digestive System Diseases Liver Diseases |
Heart Defects, Congenital Cardiovascular Abnormalities Cardiovascular Diseases Abnormalities, Multiple Congenital Abnormalities Genetic Diseases, Inborn |
ClinicalTrials.gov processed this record on May 21, 2013